United States Biotechnology & Medical Research

CDT Equity Inc (CDT)

Track

Recent insider trading activity at CDT Equity Inc. primarily consists of significant sell transactions by Nirland Ltd and Regan Andrew. The most recent trades occurred in October 2024, with Nirland Ltd executing multiple sales. Prior to this, Regan Andrew also engaged in substantial selling activity in July 2024.
Stock chart
Ticker: CDT Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Nirland Ltd
1 sale — total 96,530 USD
Sale 7 Oct 2024
Value US$2,045,527.93 | Price 328.40 | Shares 4,803
Sale 4 Oct 2024
Value US$4,874,960.19 | Price 180.90 | Shares 91,573
Sale 3 Oct 2024
Value US$156,450.00 | Price 0.10 | Shares 1,500,000
Sale 2 Oct 2024
Value US$34,250.60 | Price 0.10 | Shares 333,177
Sale 1 Oct 2024
Value US$141,375.00 | Price 0.11 | Shares 1,250,000
Sale 30 Sep 2024
Value US$122,018.76 | Price 0.12 | Shares 1,016,823
Sale 17 Jul 2024
Value US$391,092.03 | Price 0.26 | Shares 1,514,100
Sale 16 Jul 2024
Value US$3,246,447.82 | Price 0.32 | Shares 10,244,392
Sale 15 Jul 2024
Value US$248,384.92 | Price 0.25 | Shares 1,005,200
Sale 12 Jul 2024
Value US$343,424.52 | Price 0.25 | Shares 1,389,820
Sale 11 Jul 2024
Value US$87,000.00 | Price 0.29 | Shares 300,000
Sale 11 Jul 2024
Value US$173,253.33 | Price 0.30 | Shares 582,952
Sale 10 Jul 2024
Value US$50,070.00 | Price 0.33 | Shares 150,000
Sale 9 Jul 2024
Value US$33,853.38 | Price 0.44 | Shares 77,681
Sale 8 Jul 2024
Value US$18,320.73 | Price 0.51 | Shares 35,923
Sale 3 Jul 2024
Value US$640.00 | Price 0.64 | Shares 1,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-10-07 2024-10-07 S Sale
3.5
Nirland Ltd
Large shareholder
4,803 -21.5%
328.40
US$2,045,528 		4,803 -21.5% 328.40 US$2,045,528
2024-10-07 2024-10-04 S Sale
3.5
Nirland Ltd
Large shareholder
91,573 -17.0%
180.90
US$4,874,960 		91,573 -17.0% 180.90 US$4,874,960
2024-10-07 2024-10-03 S Sale
3.5
Nirland Ltd
Large shareholder
32,440 -35.4%
106.36
US$2,030,184 		32,440 -35.4% 106.36 US$2,030,184
2024-10-02 2024-10-02 S Sale
3.5
Nirland Ltd
Large shareholder
333,177 -3.3%
0.10
US$34,251 		333,177 -3.3% 0.10 US$34,251
2024-10-02 2024-10-01 S Sale
3.5
Nirland Ltd
Large shareholder
1,250,000 -10.9%
0.11
US$141,375 		1,250,000 -10.9% 0.11 US$141,375
2024-10-02 2024-09-30 S Sale
3.5
Nirland Ltd
Large shareholder
1,016,823 -8.1%
0.12
US$122,019 		1,016,823 -8.1% 0.12 US$122,019
2024-09-19 2024-07-17 S Sale
3.7
Regan Andrew
Non-Executive Director Large shareholder
1,514,100 -89.5%
0.26
US$391,092 		1,514,100 -89.5% 0.26 US$391,092
2024-09-19 2024-07-16 S Sale
3.7
Regan Andrew
Non-Executive Director Large shareholder
10,244,392 -85.8%
0.32
US$3,246,448 		10,244,392 -85.8% 0.32 US$3,246,448
2024-09-19 2024-07-15 S Sale
3.7
Regan Andrew
Non-Executive Director Large shareholder
1,005,200 -7.8%
0.25
US$248,385 		1,005,200 -7.8% 0.25 US$248,385
2024-09-19 2024-07-12 S Sale
3.7
Regan Andrew
Non-Executive Director Large shareholder
1,389,820 -9.7%
0.25
US$343,425 		1,389,820 -9.7% 0.25 US$343,425
2024-09-19 2024-07-11 S Sale
3.7
Regan Andrew
Non-Executive Director Large shareholder
300,000 -2.1%
0.29
US$87,000 		300,000 -2.1% 0.29 US$87,000
2024-09-19 2024-07-11 S Sale
3.7
Regan Andrew
Non-Executive Director Large shareholder
582,952 -3.8%
0.30
US$173,253 		582,952 -3.8% 0.30 US$173,253
2024-09-19 2024-07-10 S Sale
3.7
Regan Andrew
Non-Executive Director Large shareholder
150,000 -1.0%
0.33
US$50,070 		150,000 -1.0% 0.33 US$50,070
2024-09-19 2024-07-09 S Sale
3.7
Regan Andrew
Non-Executive Director Large shareholder
77,681 -0.5%
0.44
US$33,853 		77,681 -0.5% 0.44 US$33,853
2024-09-19 2024-07-08 S Sale
3.7
Regan Andrew
Non-Executive Director Large shareholder
35,923 -0.2%
0.51
US$18,321 		35,923 -0.2% 0.51 US$18,321
2024-09-19 2024-07-03 S Sale
3.7
Regan Andrew
Non-Executive Director Large shareholder
1,000 -0.0%
0.64
US$640 		1,000 -0.0% 0.64 US$640
Explore more

More insider trading research around CDT Equity Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America